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The mechanism for the transcriptional up-regulation of p27Kip1 due to the formation of the cell–cell contact was investigated in vascular
endothelial cells. The induction of the cell–cell contact by adding an extra number of endothelial cells activated Rac1, up-regulated p27Kip1
mRNA and protein, and also facilitated the cell cycle arrest. Transduction of the Rac1 inhibitor protein using the cell-penetrating peptide or
treatment with a Rac1 inhibitor NSC23766 inhibited the p27Kip1 up-regulation and delayed the cell cycle arrest. Rac1 was therefore suggested to
mediate the contact-induced transcriptional up-regulation of p27Kip1. The role of Rac1 in the regulation of the p27Kip1 promoter activity was next
examined with a luciferase reporter assay. The promoter activity was increased by inducing the cell–cell contact, which was significantly inhibited
by the Rac1 inhibitory protein and NSC23766. The evaluation of various truncated promoter regions determined region −620 to −573 nucleotides
from the initiation codon to be responsible for the contact-induced, Rac1-dependent activation of the p27Kip1 promoter. The present study thus
demonstrated for the first time that the activation of Rac1 due to the cell–cell contact plays a critical role in the transcriptional up-regulation of
p27Kip1 in vascular endothelial cells.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cell cycle; Promoter; Cyclin-dependent kinase inhibitor; Expression; Protein transduction1. Introduction
The growth of vascular endothelial cell is known to be re-
gulated by homophilic cell–cell contact both in situ and in culture
[1], thus contributing to the formation of a monolayer lining of
endothelial cells, angiogenesis and the functional differentiation
in vascular tissues [2]. A disruption of the cell–cell contact re-
initiates the endothelial growth, which may be related to the
endothelial dysfunction seen in such vascular diseases as athe-
rosclerosis. However, the mechanism of the contact-induced
growth arrest still remains to be elucidated.
A cyclin-dependent kinase inhibitor p27Kip1 has been shown
to play a crucial role in the contact-induced growth arrest [3–6].
The expression of p27Kip1 is regulated by both transcriptional and
post-transcriptional mechanisms. The ubiquitin-proteasomal or
other proteolytic mechanisms plays a major role in the rapid⁎ Corresponding author. Tel.: +81 92 642 5550; fax: +81 92 642 5552.
E-mail address: khirano@molcar.med.kyushu-u.ac.jp (K. Hirano).
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doi:10.1016/j.bbamcr.2007.08.001degradation and inactivation of p27Kip1 seen before the quiescent
cells return to the cell cycle and progress to the S phase [7–10].
The transcriptional repression also contributes to the down-
regulation of p27Kip1 prior to the platelet-derived growth factor-
induced progression to the S phase in smooth muscle [11]. On the
other hand, the mechanism of the up-regulation of p27Kip1 during
the contact-induced growth arrest still remains to be elucidated.
We have previously demonstrated the transcriptional up-regula-
tion and the stabilization of mRNA to be associated with an
increase in the expression of p27Kip1 during the contact-induced
growth arrest in vascular endothelial cells [4]. However, the
precise mechanisms of the transcriptional up-regulation of
p27Kip1 by cell–cell contact still remain to be elucidated.
The genomic structure of the p27Kip1 gene has been partially
determined in humans andmice [12–15]. As a result, at least three
exons have been suggested to exist. The coding region of p27Kip1
resides on exons 1 and 2, while exon 3 contains only an un-
translated region [12]. The p27Kip1 gene is TATA-less, and the
region required for basal promoter activity has been determined to
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D, interferon-β and triiodothyronine have been shown to activate
the transcription of p27Kip1 [16–20]. Synergistic action of Sp1
and NF-Y has been reported to play an important role in the
vitamin D-induced transcriptional activation [20]. However, the
intracellular signal transduction and the cis- and trans-acting
elements involved in the contact-induced transcriptional up-
regulation of p27Kip1 still remain to be elucidated.
The formation of the cell–cell contact has been shown to
activate Rho family proteins [21]. The type of Rho protein that is
activated due to the cell–cell contact varies with the type of cell
and the type of adhesionmolecule involved [21]. The engagement
ofVE-cadherin or nectin has been shown to be associatedwith the
activation of Rac1 but not RhoA [22,23]. The activation of Rho
family proteins is considered to regulate cell adhesion complex,
cytoskeletal organization, cell polarity and gene expression [21].
A role of Rac1 in the contact-induced up-regulation of the p27Kip1
transcription thus remains to be investigated.
In the present study, we investigated the role of Rac1 in the
transcriptional up-regulation of p27Kip1 due to the homophilic
cell–cell contact in vascular endothelial cells. The involvement
of Rac1 was examined by introducing a Rac1 inhibitory protein
into the intact endothelial cells. We herein demonstrated, for the
first time, that the Rac1 mediates the cell–cell contact-induced
activation of the p27Kip1 promoter.Fig. 1. The experimental protocols to induce the formation of the cell–cell contact. B
time 0. The cells were transfected with reporter plasmids 24 h later. After 4-h transfec
without adding the extra number of BAECs or HeLa cells (8×105 cells/60-mm dish)
after adding the extra number of cells. The transfection step was omitted in the ex
evaluated by immunofluorescence staining of β-catenin at the time point indicated by
and HeLa cells (h) at 8×105 cells/60-mm dish are shown for comparison purposes.2. Materials and methods
2.1. Cell cultures
The primary cultures of bovine aortic endothelial cells (BAECs) and porcine
aortic endothelial cells (PAECs) were obtained as previously reported [4,24].
BAECs, PAECs and HeLa cells were cultured and maintained in Dulbecco's
modified Eagle medium (DMEM) (Sigma, St. Louis, MO, USA) containing
10% (v/v) fetal bovine serum and antibiotics.
2.2. Protocols to study the effect of the formation of the cell–cell contact
on the Rac1 activity, the S phase progression, the level of p27Kip1 mRNA
and protein, and p27Kip1 promoter activity
The experimental protocols are summarized in Fig. 1. The cells at con-
fluence were harvested by trypsinization and then were replated at a confluent
density of 25% (4×105 cells/60-mm dish). When the promoter activity was
studied, the cells were transfected 24 h later with 1 μg pGL3-reporter plasmid
and 0.5 μg phRL-TK in 2.5 ml DMEM containing 10 μg lipofectamine
(Invitrogen, Carlsbad, CA, USA) and 2 μg lipofectamine PLUS™ reagent
(Invitrogen). After the 4-h transfection, the cells were washed in PBS twice, and
then the cell culture was resumed in DMEM containing 10% (v/v) serum and
antibiotics, either with or without the addition of the extra number (8×105 cells/
60-mm dish) of endothelial cells or HeLa cells. When the effects of a Rac1
inhibitor protein TATHA-PBD or a Rac1 inhibitor NSC23766 were examined, it
was added 2 h after adding the extra cells. When studying the Rac1 activity, the
S phase progression, and the p27Kip1 expression, the transfection step was
omitted.AECs were plated at 4×105 cells/60-mm dish (25% of the confluent density) at
tion step, indicated by shaded boxes, the cell culture was resumed either with or
, and with or without TATHA-PBD. TATHA-PBD was added to the culture 2 h
periments without the promoter assay. The formation of cell–cell contact was
arrows in each protocol (a–f). The images obtained 24 h after plating BEACs (g)
Scale bar=25 μm.
Fig. 2. Effect of the induction of cell–cell contact on the cell cycle progression in
PAECs. (A) Representative time courses of the changes in the S phase fraction
after plating PAECs at 4×105 cells/60-mm dish (open circles). Closed circles,
the S phase progression following the addition of the extra number of cells
(8×105 cells/60-mm dish) at 24 h after the initial plating at 4×105 cells/60-mm
dish. Closed triangles, the cell cycle progression when the same number of cells
(8×105 cells/60-mm dish) was plated in the absence of the pre-seeded cells.
Data obtained with the triplicate measurement in one series of experiment are
shown. (B) Comparison of the fraction of the S phase at the time points indicated
as a, b, and c in panel A. The fraction of the S phase in the 1:1 mixture of the
samples of a and b (a+b) is also shown for comparison purposes. The data are
the mean±S.E.M. (n=3). ⁎Pb0.05.
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The cells were harvested by trypsinization and fixed in 50%(v/v) methanol at
−20 °C for more than 20 min. The cells were then stained with 50 μg/ml
propidium iodide (Sigma) in PBS containing 50 μg/ml RNase A (Sigma) at
room temperature for 20 min, as previously described [4]. A total of 20,000 cells
were analyzed with a flow cytometer FACSCalibur (Becton Dickinson, San
Jose, CA, USA). ModFit LT ver 2.0 software program (Verity Software House,
Topsham, Maine, USA) was used to determine the fraction of the S phase of the
cell cycle.
2.4. Analysis of S phase entry by 5-bromo-2′-deoxy-uridine incorporation
The S phase entry of the cells was examined by the nuclear incorporation of
5-bromo-2′-deoxy-uridine (BrdU) as previously described [4]. In brief, the cells
were labeled with 10 mM BrdU for 1 h, and then fixed in 70%(v/v) ethanol,
50 mM glycine (pH 2.0) at −20 °C. The incorporated BrdU was detected using a
BrdU labeling and detection kit (Roche Diagnostics, Tokyo, Japan). The fraction
of BrdU-positive cells was determined by counting N500 cells in one ex-
periment, as previously described [4].
2.5. Immunofluorescence staining of β-catenin
Immunofluorescence staining of β-catenin in BAECs was performed as
previously described [4]. In brief, the cells were fixed with ethanol at −20 °C for
20 min, and then blocked with 5%(w/v) bovine serum albumin in PBS at room
temperature for 60 min. β-Catenin was detected by the mouse monoclonal
antibody 15B8 (Sigma), followed by a Texas red-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA). The fluorescence
images were obtained under a fluorescence microscope (Leica DMRXA; Leica,
Wetzlar, Germany) with a 63× objective lens and a CCD camera ProgRes C14
(Jenoptik, Jena, Germany), and saved as TIFF files.
2.6. Preparation of recombinant proteins
A fragment containing the Rac1/Cdc42-binding domain (PBD; residues 67–
150) of human p21-activated protein kinase-1 and a fragment containing the
RhoA-binding domain (RB; residues 941–1075) of Rho kinase were expressed
as recombinant proteins containing a hexahistidine tag, either with (TATHA-
PBD, TATHA-RB) or without ((His)6-PBD, (His)6-RB) a cell-penetrating
peptide of the human immunodeficiency viral Tat protein and a hemagglutinin
(HA) tag at their N-terminus, as previously described [24–27]. The recombinant
proteins were expressed in Escherichia coli JM109, and then affinity-purified
through Ni2+-loaded Hi-Trap chelating column, as previously described [25].
The recombinant proteins were eluted in 20 mM Tris–HCl, 500 mM imidazole,
500 mM NaCl, 1 mM β-mercaptoethanol, pH 8.0 and directly used in
experiments. The protein concentration was estimated with a Coomassie protein
assay kit using bovine serum albumin as a standard (Pierce, Rockford, IL, USA).
The purity of the proteins was N90% as evaluated on SDS-PAGE.
2.7. Isolation of genomic clones for porcine p27Kip1 genes
A plaque hybridization technique and the probes labeled with [α32P]-dCTP
were utilized to screen for the p27Kip1 genes in a porcine liver genomic library
(Stratagene, La Jolla, CA, USA). A 340-bp PCR product corresponding to
region 147–486 nt of the p27Kip1 cDNA clone (accession number: AB031955,
[28]) or a 682-bp product corresponding to region 473–1154 nt of the p27Kip1R
cDNA clone (accession number: AB031958, [28]) was used as screening
probes. The phage DNA (∼40 μg) was isolated from the plate lysate (∼100 ml)
of the positive clones obtained after repeated hybridization. The library inserts
were excised out by digestion with NotI and then were ligated to the NotI-
digested pEGFP-N1 (Clontech, Palo Alto, CA, USA), for sequencing and
further analyses. The nucleotide sequence data of the full-length porcine p27Kip1
gene have been deposited into the GeneBank/EMBL/DDBJ databases under the
accession number of AB083336.2.8. Construction of the luciferase reporter plasmids for the porcine
p27Kip1 promoter assay
The promoter region of the porcine p27Kip1 gene with a various length was
obtained by PCR amplification with a genomic clone in pEGFP-N1 as a template.
PCR products were then subcloned into a pGL3-basic vector (Promega, Madison,
WI, USA). The reporter plasmids thus obtained were pGL3-Kip1 (−686 to −19),
pGL3-Kip1 (−648 to −19), pGL3-Kip1 (−620 to −19), pGL3-Kip1 (−573 to
−19), pGL3-Kip1 (−501 to −19), pGL3-Kip1 (−335 to −19), pGL3-Kip1 (−164
to−19), pGL3-Kip1 (−130 to−19) and pGL3-Kip1 (−106 to−19). The number in
parentheses indicates the residue number at the 5′- and 3′-end of the promoter
region, while the first base of the translation initiation codonwas assigned to be +1
(Fig. 8A). The overlapping extension PCR [29] was used to construct pGL3-Kip1
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and−620 in pGL3-Kip1 (−686 to−19) to disrupt the binding sites for Sp1 [15] and
MZF1 [30]. The sequences of all inserts were determined to contain no unintended
mutations in comparison to those of the original genomic clone. phRL-TK
(Promega) was used as a reference reporter to normalize the transfection efficiency.
2.9. Luciferase assay
The promoter activity was evaluated 48 h after the initial plating, i.e., 20 h
after terminating the transfection of the reporter plasmid (Fig. 1). The cells were
washed in PBS twice, and then they were lysed in the passive lysis buffer
(Promega). The lysates were kept frozen at −80 °C until use. After thawing and
clarification of the lysates by a brief centrifugation on a tabletop microcentrifuge
(13,000×g, 30 s, room temperature), the luciferase activity was determined using
dual-luciferase reporter assay system (Promega) and a luminometer Lumat
LB9507 (Berthold Technologies, Bad Wildbad, Germany). The activity of
firefly luciferase was normalized by that of Renilla luciferase, and the value
obtained with pGL3-control vector containing a SV40 promoter (Promega) was
assigned to be 100% under each condition. The value obtained with pGL3-Kip1
(−686 to −19) without the addition of the extra cells was then assigned a value
of 1 (Fig. 5A).
2.10. Pull-down assay for the GTP-bound forms of Rac1 and RhoA
The cell extract (500 μg protein) was prepared in the lysis buffer (50 mM
Tris–HCl, pH 7.2, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate,
0.1% (w/v) SDS, 500 mM NaCl, 10 mM MgCl2, 10 μg/ml leupeptin, 10 μg/ml
aprotinin, 10 μM 4-aminidophenylmethane sulfonyl fluoride), and then it was
incubated with 25 μg TATHA-PBD or TATHA-RB for 30 min at 4 °C, as
previously described [26]. The mixture was then incubated with Ni2+-nitrilo
acetate resin (Qiagen) at 4 °C for 1 h. The resin was collected by a brief
centrifugation and thoroughly washed in the resin wash buffer (50 mM Tris–
HCl, 1% (v/v) Triton X-100, 150 mMNaCl, 10 mMMgCl2, 10 μg/ml leupeptin,Fig. 3. Activation of Rac1 due to the formation of the cell–cell contact in PAECs. (A) R
Cdc42 in the cell lysates (10 μg proteins) of BAECs and PAECs at confluence. The ch
Representative photos and the summary of the immunoblot detection of the total and G
(EC+EC) and without (EC) the addition of the extra number of cells. After the immun
staining. To normalize the possible loading variation, the level of total RhoA or Rac1
GTP-bound forms of RhoA and Rac1 was normalized by the level of the pull-down p
normalized by the level of total RhoA or Rac1 (GTP-RhoA or Rac1/total RhoA or
assigned a value of 1. The data are the mean±S.E.M. (n=5). ⁎Pb0.05 vs. EC.10 μg/ml aprotinin, 10 μM 4-aminidophenylmethane sulfonyl fluoride, pH 7.2),
and the bound protein was directly eluted in 50 μl SDS-sample buffer (50 mM
Tris–HCl, pH 6.8, 2% (w/v) SDS, 5% (v/v) glycerol, 5% (v/v) 2-
mercaptoethanol, 0.01% (w/v) NaN3, 0.01% (w/v) bromophenol blue) by
heating at 100 °C for 5 min. The equal volume (20 μl) of the resin eluates was
subjected to SDS-PAGE on 7.5–20% (w/v) gradient polyacrylamide gel and
immunoblot analysis using anti-Rac1 (No.610650; BD Bioscience, San Jose,
CA, USA) and anti-RhoA (sc-418; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) antibodies. The total lysates were also subjected to immunoblot analysis
for the expression of RhoA, Rac1 and Cdc42 (anti-Cdc42 antibody; sc-87, Santa
Cruz Biotechnology). The immune complex was detected with an enhanced
chemiluminescence technique (ECL plus kit, Amersham, Buckinghamshire,
UK). The light emission was detected and analyzed with ChemiDoc XRS-J and
Quantity One software (BioRad, Tokyo, Japan). After immunoblot detection, the
polyvinylidene difluoride membranes were stained with naphtol blue black to
detect the bands corresponding to actin in the total lysate and the pull-down
probes in the bound fraction. The density of RhoA and Rac1 in the total lysate
(total RhoA and Rac1) was normalized by the density of actin, while that seen in
the bound fraction (GTP-bound forms) was normalized by the density of the
pull-down probes and the density of total RhoA or Rac1 (Fig. 3).
2.11. RT-PCR analysis of p27Kip1 mRNA expression
The total RNAwas isolated and then subjected to the RT reaction for p27Kip1
andβ-actin as previously described [4]. Thereafter, the RT products were subjected
to either real-time PCR or regular PCR followed by agarose gel electrophoresis.
The purified DNA of the pEGFP-Kip1 plasmid [29] and the RT-PCR product ofβ-
actin obtained with the total RNA of PAECs were used as a standard template for
p27Kip1 and actin, respectively, to evaluate the linearity of the analysis. The real-
time PCR was performed in a 20-μl reaction mixture with a LightCycler (Roche
Diagnostics,Mannheim, Germany). The PCR reaction for both p27Kip1 andβ-actin
was composed of the initial 1-min denaturation at 95 °C, followed by the
subsequent amplification step consisting of 15-s denaturation at 95 °C, 10-s
annealing at 55 °C and 20-s extension at 72 °C. The linear relationship between theepresentative photos of three separate immunoblot detection of RhoA, Rac1 and
emiluminescence images were obtained with the same exposure time (5 min). (B)
TP-bound forms of RhoA and Rac1 48 h after the initial plating of PAECs, with
odetection, actin and the pull-down probes were visualized by naphtol blue black
was normalized by the level of actin (total RhoA or Rac1/actin), and the level of
robe (GTP-RhoA or Rac1/Probe). The level of GTP-RhoA or Rac1 was further
Rac1). The value obtained without adding the extra number of cells (EC) was
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number was obtained with a range of 1 pg to 10 ng for p27Kip1, and 1 fg to 1 pg for
β-actin (data not shown).However, the RT products of the cell samples did not give
the crossing cycle number within the linear range for p27Kip1 (data not shown).
We thus conducted a PCR analysis as previously described with minor
modifications [4]. The PCR reaction for p27Kip1 was composed of the initial
denaturation at 94 °C for 2 min and the subsequent 30-cycle amplification step
consisting of 1-min denaturation at 94 °C, 1-min annealing at 52 °C and 1-min
extension at 72 °C. The PCR reaction for β-actin was composed of the initial
denaturation at 94 °C for 2 min and the subsequent 25-cycle amplification step
consisting of 1-min denaturation at 94 °C, 1-min annealing at 55 °C and 1-min
extension at 72 °C. The PCR products were separated on 3% (w/v) agarose gel
containing 0.5μg/ml ethidium bromide. The densities of the bands of the fluorescent
images obtained with a gel documentation system equipped with a CCD camera
(Printograph; Atto, Tokyo, Japan) were analyzed using the Quantity One software
program (Bio-Rad). The linear relationship between the amount of the input standard
template and the density of the band was obtained with a range of 0 to 1.0 pg for
p27Kip1 and 0 to 100 fg for actin (data not shown). The density of the PCR products
obtained with the cell samples was within this linear range for both p27Kip1 and β-
actin. The levels of p27Kip1 were then normalized by the level of β-actin obtainedFig. 4. Rac1-dependent up-regulation of the p27Kip1 mRNA and protein expression
(A) A representative photo and a summary of RT-PCR analysis of the expression of p2
number of PAEC (EC+EC), in the presence or absence of 100 nM TATHA-PBD
representative photo and a summary of the immunoblot analysis of the expression of
extra number of PAEC in the presence or absence of the indicated concentrations of
adding the extra number of PAEC in the presence or absence of 100 nM TATHA-PBD
EC in B); n.s., not significantly different.from the corresponding RT product, and the value obtained without addition of the
extra number of endothelial cells and TATHA-PBD was assigned a value of 1.
2.12. Immunoblot analysis of p27Kip1 protein expression
The level of p27Kip1 protein was analyzed by an immunoblot analysis as
previously described [4]. The cell homogenatewas prepared in the same lysis buffer
as that used for the pull-down assay, and then the equal amount of protein was
subjected to SDS-PAGE on 15%polyacrylamide gel and the following immunoblot
detection using anti-p27Kip1 antibody (No. 610242; BD Bioscience) and the
horseradish peroxidase-conjugated secondary antibody (Sigma). The immune
complexwas detected and analyzed as described above.After the immunodetection,
the membrane was stained with naphtol blue black to visualize the band of actin.
The density of p27Kip1 as detected by immunoblot was normalized by the density of
actin, and then the value obtained under control condition was assigned a value of 1.
2.13. Other materials
NSC23766, a Rac inhibitor [31], was purchased from Calbiochem (San
Diego, CA, USA), and dissolved at 10 mM in distilled H2O.and the cell cycle arrest due to the formation of the cell–cell contact in PAECs.
7Kip1 mRNA 28 h after the initial plating of PAECs, i.e., 4 h after adding the extra
. The control culture did not receive the extra number of cells (EC). (B) A
p27Kip1 protein 48 h after the initial plating of PAECs, i.e., 24 h after adding the
TATHA-PBD or NSC23766. (C) The fraction of BrdU-positive cells 24 h after
. The data are the mean±S.E.M. (n=4 for A, 5 for B and C). ⁎Pb0.05 (vs. EC+
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The data are the means±S.E.M. of the indicated number of independent
experiments. The analysis of variance (ANOVA) evaluated any statistical
significance. A value of Pb0.05 was considered to be significantly different.3. Results
3.1. Effect of the formation of the cell–cell contact on the cell
cycle progression in PAECs
The formation of the cell–cell contact was induced according
to a protocol shown in Fig. 1, while the transfection step was
omitted when evaluating the cell cycle progression. After plating
PAECs at 4×105 cells/60-mm dish (∼25% of the confluent
density), the cell cycle reached the first peak of the S phase at
24 h, and the lower second peak at 36 h. Thereafter, the fraction
of the S phase gradually decreased (Fig. 2A, lower panel). When
plated at 8×105 cells/60-mm dish (∼50% of the confluent
density), the cell cycle phase reached the peak of the S phase 24 h
after the plating, and then the fraction of the S phase rapidlyFig. 5. Activation of the p27Kip1 promoter activity by the homophilic cell–cell contact
plating density (16×105 cells/60-mm dish corresponded to the confluent density). The
obtained with a plating density of 4×105 cells/60 mm to be 1. The data are the mean±
cells/60-mm dish. (B) The activity of the various promoter regions without (EC) and
HeLa). The promoter activity was expressed as the relative values, while assigning the
of cells to be 1. The data are the mean±S.E.M. of the indicated number of experiment
cells for each construct. The reporter constructs are schematically shown; gray boxes, t
LUC, a coding sequence of the firefly luciferase.decreased (Fig. 2A, upper panel). These observations were
consistent with the findings of our previous report [4]. When
8×105 cells/60-mm dish were added 24 h after the initial plating
at 4×105 cells/60-mm dish, the subsequent cell cycle progres-
sion to the S phase was substantially suppressed (Fig. 2A, lower
panel). The fraction of the S phase seen 24 h after the addition of
the cells was much lower than that seen 24 h after plating at
8×105 cells/60-mm dish, while it was also significantly lower
than that seen in the mixture of the time-matched samples
obtained 48 h after the plating at 4×105 cells/60-mm dish and
those obtained 24 h after the plating at 8×105 cells/60-mm dish
(Fig. 2B).
3.2. Activation of Rac1 and up-regulation of p27Kip1 by the
formation of the cell–cell contact in PAECs
RhoA and Rac1 are readily detected in PAECs and BAECs,
while Cdc42 was scarcely detected (Fig. 3A). We thus examined
the effect of the formation of the cell–cell contact on the activity
of Rac1 and RhoA proteins in PAECs. Because of the difference
in the cell number due to the experimental protocol, the samein BAECs. (A) The p27Kip1 promoter activities shown as a function of the initial
promoter activity was expressed as the relative values, while assigning the value
S.E.M. (n=3). ⁎Pb0.05 vs. the value obtained with a plating density of 4×105
with the addition of the extra number of BAECs (EC+EC) or HeLa cells (EC+
value obtained with region −686 to −19 and without addition of the extra number
s. †Pb0.05; ⁎Pb0.05 vs. the values obtained without adding the extra number of
he p27Kip1 promoter regionwith the residue numbers at 5′- and 3′-end; boxes with
Fig. 6. Inhibition of the contact-induced activation of the p27Kip1 promoter activity
by transduction of Rac1 inhibitory protein in BAECs. The p27Kip1 promoter
activity in BAECs in the presence of TATHA-PBD (A) or (His)6-PBD (B). The
reporter construct is schematically shown as in Fig. 5. The recombinant proteins
were added at the indicated concentrations 2 h after terminating the 4-h transfection
step and resuming the cell culture with (EC+EC) and without (EC) the addition
of the extra number of cells (8×105 cells/60-mm dish). The promoter activity
was expressed as a relative value, while assigning the value obtained without
the addition of the extra number of cells and the recombinant proteins to be 1. V,
the values obtained with vehicle for the recombinant proteins. The data are the
mean±S.E.M. (n=5 for TATHA-PBD, n=3 for (His)6-PBD). ⁎Pb0.05 vs. the
values obtained in the absence of the recombinant proteins.
Fig. 7. Inhibition of the contact-induced activation of the p27Kip1 promoter activity
by a Rac1 inhibitor NSC23766 in BAECs. The promoter activity of the reporter
construct, as schematically shown on top, in the absence and presence ofNSC23766
in BAECs. NSC23766was added 2 h after terminating the 4-h transfection step and
resuming the cell culture with (EC+EC) and without (EC) the addition of the extra
number of cells. The promoter activity was expressed as a relative value, while
assigning the value obtained without the addition of the extra number of cells to be
1. The data are themean±S.E.M. (n=4). ⁎Pb0.05 vs. EC+ECwithoutNSC23766.
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assay. The addition of the extra number of cells had no effect on
the total amount of RhoA or Rac1. However, it increased the
amount of the GTP-bound form of Rac1 approximately 2-fold of
that seen without addition of the cells (Fig. 3B), while it had no
significant effect on the amount of the GTP-bound form of RhoA
(Fig. 3B). The addition of the extra number of cells also up-
regulated the level of p27Kip1 mRNA, and this up-regulation of
p27Kip1 was abolished by the transduction of 100 nM TATHA-
PBD (Fig. 4A). The level of p27Kip1 proteinwas also up-regulated
by the addition of the extra number of cells, and this up-regulation
was inhibited by either TATHA-PBD or NSC23766 (Fig. 4B).
The functional significance of the Rac1-dependent p27Kip1 up-
regulation was supported by the observation that TATHA-PBDsignificantly increased the S phase fraction seen 24 h after adding
the extra number of PAECs, as evaluated by the BrdU
incorporation (Fig. 4C).
The results shown above suggested that the formation of the
cell–cell contact activated Rac1, thereby up-regulating the
p27Kip1 mRNA and protein, and also facilitating the cell cycle
arrest. In the following studies, the role of Rac1 in the regulation
of the p27Kip1 promoter activity was investigated.
3.3. Density-dependent activation of p27Kip1 promoter in
BAECs
The effect of the plating density on the p27Kip1 promoter
activity was first investigated. Since the pilot experiments showed
the transfection efficiency of PAECs to be too low to quan-
titatively investigate the promoter activity, BAECswere thus used
to evaluate the activity of the p27Kip1 promoter. As shown in
Fig. 5A, the promoter activity of region −686 to −19 increased
depending on the plating density, thus reaching a maximum at the
density of 12×105 cells/60-mm dish, which corresponded to
approximately 75% of the confluence density. Lowering plating
density below 4×105 cells/60-mm dish caused no significant
decrease in the promoter activity. The activity obtained with the
plating density of 4×105 cells/60-mm dish was thus used as the
basal activity and it was assigned a value of 1.
3.4. Activation of the p27Kip1 promoter by induction of the
homophilic cell–cell contact
We further investigate the cell–cell contact-induced activation
of the p27Kip1 promoter, according to the protocol shown in
Fig. 1. The addition of BAECs increased the promoter activity of
region −686 to −19 approximately 2-fold compared to that seen
Fig. 8. The region responsible for the contact-induced Rac1-dependent activation of the p27Kip1 promoter. (A) The sequences of the promoter region of the porcine
p27Kip1 gene (accession number; AB083336), numbered by assigning the first base of the translation initiation codon to be +1. The arrows with numbers indicate the
residues at the 5′- and 3′-end of the promoter regions used in the luciferase assay (Figs. 5–8). Triangles at −491, −484, −456 indicate resides corresponding to the
transcription initiation sites determined in humans and mice [13,15,34]. The binding sites for the transcription factors are indicated by the lines either just over or under
the nucleotide sequences, with the name of the transcription factors. (B) The activity of the various promoter regions obtained without (EC) and with addition of the
extra number of BAECs (EC+EC), and in the presence or absence of 100 nM TATHA-PBD. The reporter constructs are also schematically shown as in Fig. 5. TT
represents the mutations of GC at the position of −621 and −620. The promoter activity was expressed as relative values, while the value obtained with the region
−686 to −19 and without the addition of the extra number of cells and the recombinant protein was assigned a value of 1. The data are the mean±S.E.M. of the
indicated number of experiments. ⁎Pb0.05; n.s., not significantly different.
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addition of HeLa cells significantly increased the promoter
activity of the region −686 to −19, but to the much lesser extent
than that seen with BAECs (Fig. 5B, EC+HeLa). The addition of
BAECs did induce the formation of the cell–cell contact to the
higher level than that seen without addition of the extra BAECs
(Fig. 1a, c). HeLa cells do not expressβ-catenin to the appreciablelevel (Fig. 1h). The addition of HeLa cells to BAECs did not
induce formation of the dense cell–cell contact (Fig. 1e).
The basal activity seen without addition of the extra number of
cells gradually decreased as the promoter regions were shortened
(Fig. 5B). The promoter activity of the regions −501 to −19 and
−335 to −19 significantly increased in response to the addition of
BAECs by approximately 1.7- and 1.6-fold, respectively, while
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further deletion of −335 to −165 abolished the responsiveness to
the addition of BAECs (Fig. 5B).
3.5. Inhibition of the Rac1 signaling inhibited the
contact-induced activation of the p27Kip1 promoter
TATHA-PBD concentration dependently inhibited the activa-
tion of the promoter activity of region−686 to−19 induced by the
addition of the extra number of BAECs (Fig. 6). The basal activity
that was seen without the addition of the cells was also slightly,
but significantly, inhibited by TATHA-PBD (Fig. 6). The
maximal inhibitory effect on both basal and activated promoter
activity was observed with 30–100 nM TATHA-PBD. Such
effective concentrations are thus consistent with those seen for the
inhibitory effect on the cell cycle progression in our previous
report [24]. The addition of the cells in the presence of 100 nM
TATHA-PBD increased the promoter activity to the level similar
to that seen with the addition of HeLa cells (Fig. 5 vs. Fig. 6). In
contrast, the control recombinant protein, (His)6-PBD, which
lacks a cell-penetrating peptide, had no significant effect on both
basal and activated promoter activity (Fig. 6). The addition of
TATHA-PBD had no apparent effect on the immunofluorescence
staining of β-catenin (Fig. 1a vs. b; c vs. d; e vs. f). The contact-
induced activation of the p27Kip1 promoter activity was also
inhibited by a Rac1 inhibitor, NSC23766 in a concentration-
dependent manner (Fig. 7). An inhibition similar to that seen with
100 nM TATHA-PBD was obtained with 50 μM NSC23766.
3.6. The promoter region responsible for the contact-induced,
Rac1-dependent transcriptional activation of p27Kip1 gene
All promoter regions −686 to −19, −501 to −19 and −335 to
−19 increased their activity in response to the formation of the
cell–cell contact (Figs. 5 and 6). However, the inhibitory effect of
TATHA-PBD on the promoter activity was observed only with
region−686 to−19 (Fig. 8B).We thus further investigated region
−686 to−501 for the sequences responsive to Rac1 (Fig. 8B). All
regions investigated increased their promoter activity in response
to the formation of the cell–cell contact (Fig. 8B). However,
TATHA-PBD significantly inhibited the contact-induced activa-
tion of the promoter activity seenwith regions−686 to−19,−648
to −19 and −620 to −19 (Fig. 8B). A deletion of region −620 to
−574 (regions −573 to −19) abolished such an inhibitory effect
of TATHA-PBD. TATHA-PBD also significantly inhibited the
promoter activity of pGL3-Kip1 (−686 to −19:TT), which
contained mutations in the binding sites for Sp1 [15] and MZF1
[30] (Fig. 8B).
4. Discussion
We previously reported that the formation of the cell–cell
contact induced a transcriptional up-regulation of p27Kip1 in
vascular endothelial cells [4]. However, the mechanism of the
contact-induced activation of the transcription of the p27Kip1 gene
remains to be elucidated. The present study demonstrated that the
induction of the homophilic endothelial cell–cell contact ac-tivated the p27Kip1 promoter, increased the level of p27Kip1
mRNA and protein, and also facilitated the cell cycle arrest, all of
which were inhibited by inhibiting the Rac1 activity. A pull-down
assay did reveal an increase in the activity of Rac1 but not RhoA
upon formation of the homophilic cell–cell contact. Collectively,
our observations suggest that the formation of the homophilic
cell–cell contact activated Rac1, which in turn induced the
transcriptional up-regulation of p27Kip1, thereby increasing the
p27Kip1 expression and facilitating the contact-induced growth
arrest. Our previous report demonstrated a temporal correlation
between the p27Kip1 up-regulation and the cell cycle arrest [4].
The observations of the present study therefore suggest the
existence of a functional link between the 27Kip1 up-regulation
and the cell cycle arrest. Rac1 has been reported to be involved in
the angiotensin II-induced up-regulation of 27Kip1 [32]. The
present study thus provides the first evidence for the involvement
of Rac1 activation in the contact-induced transcriptional up-
regulation of the p27Kip1 gene.
It is noteworthy that the addition of HeLa cells slightly, but
significantly, increased the promoter activity. However, such an
activation of the HeLa cells was much lower than that seen with
the endothelial cells. These observations suggest that somemech-
anisms other than the homophilic cell–cell contact may also
contribute to the activation of the p27Kip1 promoter. Such addi-
tional mechanisms may include non-homophilic but still specific
cell adhesion mechanisms or some non-specific mechanism
caused by cell crowding [33]. It should also be noted that the
inhibition of Rac1 did not completely inhibit the activation of the
p27Kip1 promoter by the formation of the homophilic cell–cell
contact. This observation suggests the involvement of some
pathways other than Rac1 in the cell–cell contact-induced acti-
vation of the p27Kip1 promoter. However, the promoter activity
obtained with TATHA-PBD was similar to that obtained with
HeLa cells. These observations thus suggest that Rac1 may be
specifically involved in the activation of the p27Kip1 promoter due
to the homophilic cell–cell contact.
An analysis of variously truncated promoter regions of the
p27Kip1 gene revealed two functional regions: regions −335 to
−165 and −620 to −574. The deletion of region −335 to −165
caused a loss of responsiveness to the formation of the cell–cell
contact. However, this region is considered to be included in the
transcript of p27Kip1 as a 5′-untranslated region, according to the
transcription initiation sites determined in humans and mice
[13,15,34]. Therefore, this region could be involved in the post-
transcriptional regulation of p27Kip1 in response to the formation
of the cell–cell contact. However, it is also possible that the effect
of the deletion of this region on the luciferase activity may not be
specific. Both the basal activity and the responsiveness to the
formation of the cell–cell contact decreased as the promoter
region was shortened (Fig. 5B). Some degree of responsiveness
may be linked to the basal activity. The deletion of region−335 to
−165 might have decreased the basal activity to the critically
lower level to support the responsiveness to the formation of the
cell–cell contact.
On the other hand, region−620 to−574 is suggested to contain
sequences which are responsible for the Rac1-dependent activa-
tion of the p27Kip1 promoter. Many investigations independently
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transcription factors as Sp1, NF-Y, CTF, or E2F1 and also to
contribute to the up-regulation of p27Kip1 in response to vitamin D
inU937 cell, tamoxifen in human lung cancer cells, or galectin-1 in
HT-29 cells [13–15,20,35–38]. The region −620 to −574 iden-
tified in the present study is thus located just up-stream of this hot
region. The database search [39] identified a binding site forMZF1
[30,40] and δEF1 [41] in region −620 to −573 (Fig. 8A).
However, the precise mechanism regarding how Rac1 regulates
the transcription of p27Kip1 gene, and the transcription factors that
are involved thus remain to be determined in a future study.
Rho proteins have been reported to play an important role in
the cell cycle progression [42]. We have reported that Rho
proteins, RhoA and Rac1, play a critical role in the S phase
progression in BAECs [24]. Adhesion to the extracellular matrix
has been shown to be associated with the activation of RhoA and
Rac1, the down-regulation of p27Kip1, and the stimulation of the
cell growth [43,44]. RhoA and Rac1, on one hand, were reported
to facilitate the proteasomal degradation of p27Kip1 and p21Cip1
[43,45]. It is thus conceivable that the adhesion to the extracellular
matrix activates Rho proteins, thereby down-regulating p27Kip1.
Our finding of the involvement ofRac1 in the contact-induced up-
regulation of p27Kip1 is thus apparently inconsistent with these
reports. The effect of Rac1 on the level of p27Kip1 may differ
depending on the situation of either cell adhesion or cell–cell
contact. The formation of cell–cell contact, as well as the cell
adhesion, have been reported to activate Rac1 [46,47]. The spatio-
temporal regulation of the Rac1 activity should thus play a critical
role in the differential control of the adhesion-induced cell growth
and the contact-induced growth arrest.
The cell-penetrating peptide-mediated protein transduction
technique [48] was used to introduce the Rac1 inhibitory protein
into the endothelial cells. A rapid introduction of the inhibitory
protein is essential when investigating the time-dependent events
such as cell cycle progression. The conventional transfection with
the plasmid or viral vectors or the knock-down of the protein
expression with an RNA interference technique causes the de-
layed effects. It is also difficult to control the level of the protein
by these methods. We therefore took advantage of the cell-
penetrating peptide-mediated protein transduction. We and others
have demonstrated that proteins can be introduced into the cells in
as short a time as 10–15 min and also in a quantitative manner
[24–27,48]. These advantages made it possible to specifically
investigate the role of Rac1 in the contact-induced activation of
the p27Kip1 promoter.
In conclusion, the present study demonstrated for the first time
that the activation of Rac1 due to the formation of the homophilic
cell–cell contact induced an activation of the p27Kip1 promoter
activity, thereby up-regulating the p27Kip1 expression and
facilitating the cell cycle arrest. Region −620 to −573 of the
p27Kip1 promoter has been identified to play a primary role in the
Rac1-dependent activation of the p27Kip1 transcription. Our
findings thus suggest the existence of a new mechanism for the
transcriptional regulation of p27Kip1 due to the cell–cell contact,
which plays an important role in the contact-induced growth arrest
in vascular endothelial cells. The transcription factor involved in
this Rac1-dependent up-regulation of the p27Kip1 transcription,however, remains to be elucidated. The cell–cell contact-induced
growth arrest is the most important physiological mechanism
regulating the growth arrest not only in endothelial cells but also
in epithelial cells. Our discovery would shed some light on the
mechanism of the contact-induced growth arrest.
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